In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial of its experimental drug CagriSema — a combination of semaglutide and a medicine called cagrilintide. People on CagriSema lost about 23% of their body weight in a 68-week study, outperforming both drugs when taken alone.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.

The Color Purple' star Whoopi Goldberg has confirmed a new advert on Instagram using her likeness to promote a weight loss drug is "phony".

Whoopi Goldberg took to The View to blast a "phony" AI weight loss ad running on social media that is using her image to promote the product.